Abstract:11555 Background: Soft tissue sarcomas (STS) are rare often malignant tumors. The primary treatment of most STS is radical resection with adjuvant radiotherapy. Our previous study showed that the use of preoperative hypofractionated radiotherapy is safe and efficient in the treatment of unselected group of patients with STS. Aim of this study was to assess the use of the treatment scheme in patients with primary STS treated in one institution. Methods: 311 patients (52% female) with primary locally advanced STS participated in this prospective trial conducted from 2010 till 2017. Median age was 55 years (range: 17-91). Median follow up is 57 months (95%CI 55-61). The most common subtypes were pleomorphic sarcoma, liposarcoma and synovial sarcoma. Median tumor size was 11cm. 258 patients (83%) had high grade tumors. The most common tumor localization were lower limbs (72%). 30% of patients received preoperative chemotherapy. For five consecutive days radiotherapy in 5 x 5Gy fraction was applied, with immediate (2-4 days) resection of the tumor. Results: In 260 patients (83.6%) clear surgical margins (R0) were obtained. 107 patients were dead at the time of the analysis.5-year overall survival is 63%. 156 (50%) had a recurrence of the disease. Local recurrence (LR) was found in 13.8% of the patients. Median time from surgery to LR was 14.7 months. In 56% of patients with LR another limb spearing radical surgery could be performed. Factors that had a significant adverse impact on LR were histological subtype (p = 0.017) and surgical margin status (p = 0.013). Factors that had a significant adverse impact on overall survival were tumor size (p 1 month), 8.3% had wound dehiscence, 1.4% required prolonged punctures of the lymph fluid, 2.3% had severe fibrosis leading to contracture of limb, 11% patients prolonged edema of the operated limb. 0.9% of patients had a fracture of the treated limb. Conclusions: In this group, with a big percentage of patients with large, high grade STS use of hypofractionated preoperative radiotherapy was associated with similar local control when compared to published studies. The early toxicity is tolerable, with a small amount of late complications.

Stereotactic Body Radiotherapy for Metastatic and Recurrent Soft Tissue Sarcoma

The Critical Role of Stereotactic Body Radiation Therapy in Multimodal Treatment of Lung Metastasis from Bone and Soft Tissue Sarcomas

Stereotactic Ablative Brachytherapy with or Without Assistance of 3D-Printing Templates for Inoperable Locally Recurrent or Oligometastatic Soft-Tissue Sarcoma: a Multicenter Real-World Study.

The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery

Clinical Features and Prognosis of 25 Cases of Soft Tissue Sarcoma with Soft Tissue Me-Tastasis

Efficacy and safety of hypofractionated preoperative radiotherapy in treatment of patient with primary locally advanced soft tissue sarcoma of limbs/trunk wall.

Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases

Advances of Systemic Treatment for Adult Soft-Tissue Sarcoma

Postoperative Intensity Modulated Radiation Therapy Provided Favorable Local Control in Patients with Soft Tissue Sarcoma of Extremities and Trunk

Neoadjuvant radiotherapy for soft tissue sarcoma in China: a preliminary result

Effect of Postoperative Adjuvant Radiotherapy on Treatment Outcome of Patients with Localized Soft Tissue Sarcoma

Clinical Observation of Local Intervention Combined with Camrelizumab and Apatinib in the Treatment of Metastatic Soft-Tissue Sarcoma

Real-world efficacy, safety data and predictive clinical parameters for treatment outcomes in advanced soft tissue sarcoma treated with combined immunotherapy and antiangiogenic therapy

Clinical Analysis of 251 Cases of Soft Tissue Sarcomas

Preoperative sequential chemotherapy and hypofractionated radiotherapy combined with comprehensive surgical resection for high-risk soft tissue sarcomas: a retrospective study

The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report

Surgical Treatment Analysis for 709 Patients with Soft Tissue Sarcoma

Efficacy and Clinical Prognostic Factors of Image-Guided 125I Seed Implantation for Locally Recurrent Soft Tissue Sarcoma

Real-world Experience with Pembrolizumab in Patients with Advanced Soft Tissue Sarcoma

Clinical efficacy of postoperative radiotherapy using shrinking field for patients with extremity soft tissue sarcoma

Stereotactic Radiation Therapy (SRT) for Brain Metastases of Multiple Primary Tumors: A Single Institution Retrospective Analysis.